Knockdown of the NHR-8 nuclear receptor enhanced sensitivity to the lipid-reducing activity of alkaloids in Caenorhabditis elegans

References

• Gissendanner CR, Crossgrove K, Kraus KA, Maina CV, Sluder AE. Expression and function of conserved nuclear receptor genes in Caenorhabditis elegans. Dev. Biol. 2004;266:399–416.10.1016/j.ydbio.2003.10.014
   PubMed Web of Science ®Google Scholar
• Maglich JM, Sluder A, Guan X, Shi Y, McKee DD, Carrick K, Kamdar K, Willson TM, Moore JT. Comparison of complete nuclear receptor sets from the human, Caenorhabditis elegans and Drosophila genomes. Genome Biol. 2001;2: RESEARCH0029:1–7.
   Google Scholar
• Lindblom TH, Dodd AK. Xenobiotic detoxification in the nematode Caenorhabditis elegans. J. Exp. Zool. A Comp. Exp. Biol. 2006;305A:720–730.10.1002/(ISSN)1552-499X
   Google Scholar
• Lindblom TH, Pierce GJ, Sluder AE. A C. elegans orphan nuclear receptor contributes to xenobiotic resistance. Curr. Biol. 2001;11:864–868.10.1016/S0960-9822(01)00236-6
   PubMed Web of Science ®Google Scholar
• Chow YL, Sato F. Screening of isoquinoline alkaloids for potent lipid metabolism modulation with Caenorhabditis elegans. Biosci. Biotechnol. Biochem. 2013;77:409–416.
   PubMed Web of Science ®Google Scholar
• Ikezawa N, Iwasa K, Sato F. Molecular cloning and characterization of methylenedioxy bridge-forming enzymes involved in stylopine biosynthesis in Eschscholzia californica. FEBS J. 2007;274:1019–1035.10.1111/j.1742-4658.2007.05652.x
   PubMed Web of Science ®Google Scholar
• Sato F, Hashimoto T, Hachiya A, Tamura K, Choi KB, Morishige T, Fujimoto H, Yamada Y. Metabolic engineering of plant alkaloid biosynthesis. Proc. Nat. Acad. Sci. 2001;98:367–372.10.1073/pnas.98.1.367
   PubMed Web of Science ®Google Scholar
• Stiernagle T. WormBook. ed. The C. elegans Research Community, WormBook, 2006. doi:/10.1895/wormbook.1.101.1. Available from: http://www.wormbook.org.
   Google Scholar
• O’ Rourke EJ, Soukas AA, Carr CE, Ruvkun G. C. elegans major fats are stored in vesicles distinct from lysosome-related organelles. Cell Metab. 2009;10:430–435.10.1016/j.cmet.2009.10.002
   PubMed Web of Science ®Google Scholar
• Lehner B, Tischler J, Fraser AG. RNAi screens in Caenorhabditis elegans in a 96-well liquid format and their application to the systematic identification of genetic interactions. Nat. Protoc. 2006;1:1617–1620.10.1038/nprot.2006.245
   PubMed Web of Science ®Google Scholar
• Li Y, Ren G, Wang YX, Kong WJ, Yang P, Wang YM, Li YH, Yi H, Li ZR, Song DQ, Jiang JD. Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes. J. Transl. Med. 2011;9:62.10.1186/1479-5876-9-62
   PubMed Web of Science ®Google Scholar
• Ma JY, Feng R, Tan XS, Ma C, Shou JW, Fu J, Huang M, He CY, Chen SN, Zhao ZX, He WY, Wang Y, Jiang JD. Excretion of berberine and its metabolites in oral administration in rats. J. Pharm. Sci. 2013;102:4181–4192.
   PubMed Web of Science ®Google Scholar
• Qiu F, Zhu Z, Kang N, Piao S, Qin G, Yao X. Isolation and identification of urinary metabolites of berberine in rats and humans. Drug Metab. Dispos. 2008;36:2159–2165.10.1124/dmd.108.021659
   PubMed Web of Science ®Google Scholar
• Zuo F, Nakamura N, Akao T, Hattori M. Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry. Drug Metab. Dispos. 2006;34:2064–2072.10.1124/dmd.106.011361
   PubMed Web of Science ®Google Scholar
• Deroussent A, Ré M, Hoellinger H, Cresteil T. Metabolism of sanguinarine in human and in rat: characterization of oxidative metabolites produced by human CYP1A1 and CYP1A2 and rat liver microsomes using liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal. 2010;52:391–397.10.1016/j.jpba.2009.09.014
   PubMed Web of Science ®Google Scholar
• Zhang HH, Wu Y, Sun ZL, Liu ZY. Identification of sanguinarine metabolites in pig liver preparations by accurate mass measurements using electrospray ionization hybrid ion trap/time-of-flight mass spectrometry. Rapid Commun. Mass. Spectrom. 2013;27:979–984.10.1002/rcm.6538
   PubMed Web of Science ®Google Scholar
• Taubert S, Hansen M, Van Gilst MR, Cooper SB, Yamamoto KR. The Mediator subunit MDT-15 confers metabolic adaptation to ingested material. PLoS Genet. 2008;4: e1000021.
   PubMed Web of Science ®Google Scholar
• Broeks A, Janssen HW, Calafat J, Plasterk RH. A P-glycoprotein protects Caenorhabditis elegans against natural toxins. EMBO J. 1995;14:1858–1866.
   PubMed Web of Science ®Google Scholar
• Kwok TC, Ricker N, Fraser R, Chan AW, Burns A, Stanley EF, McCourt P, Cutler SR, Roy PJ. A small-molecule screen in C. elegans yields a new calcium channel antagonist. Nature. 2006;441:91–95.10.1038/nature04657
   PubMed Web of Science ®Google Scholar
• Maeng HJ, Yoo HJ, Kim IW, Song IS, Chung SJ, Shim CK. P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers. J. Pharm. Sci. 2002;91:2614–2621.10.1002/(ISSN)1520-6017
   PubMed Web of Science ®Google Scholar
• Wang YX, Wang YP, Zhang H, Kong WJ, Li YH, Liu F, Gao RM, Liu T, Jiang JD, Song DQ. Synthesis and biological evaluation of berberine analogues as novel up-regulators for both low-density-lipoprotein receptor and insulin receptor. Bioorg. Med. Chem. Lett. 2009;19:6004–6008.10.1016/j.bmcl.2009.09.059
   PubMed Web of Science ®Google Scholar
• Eid SY, El-Readi MZ, Wink M. Synergism of three-drug combinations of sanguinarine and other plant secondary metabolites with digitonin and doxorubicin in multi-drug resistant cancer cells. Phytomedicine. 2012;19:1288–1297.10.1016/j.phymed.2012.08.010
   PubMed Web of Science ®Google Scholar
• Li JWH, Vederas JC. Drug discovery and natural products: end of an era or an endless frontier? Science. 2009;325:161–165.10.1126/science.1168243
   PubMed Web of Science ®Google Scholar